Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.3 USD | +6.17% | -2.05% | +700.74% |
Apr. 05 | Elevation Oncology, Inc. Announces Management Changes | CI |
Mar. 27 | Merrimack Gets $225 Million Milestone Payment, Schedules Meeting For Dissolution Plan | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 209M |
---|---|---|---|---|---|
Net income 2024 * | -45M | Net income 2025 * | -59M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.74
x | P/E ratio 2025 * |
-4.56
x | Employees | 29 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 91.95% |
1 day | +6.17% | ||
1 week | -2.05% | ||
Current month | -16.18% | ||
1 month | -6.11% | ||
3 months | +66.67% | ||
6 months | +602.27% | ||
Current year | +700.74% |
Managers | Title | Age | Since |
---|---|---|---|
Joseph Ferra
CEO | Chief Executive Officer | 49 | 21-06-16 |
Tammy Furlong
DFI | Director of Finance/CFO | - | - |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
R. Carruthers
BRD | Director/Board Member | 66 | 21-05-17 |
Timothy Clackson
BRD | Director/Board Member | 58 | 20-04-30 |
Steven Elms
CHM | Chairman | 60 | 19-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-22 | 4.05 | +6.58% | 500,444 |
24-04-19 | 3.8 | -5.24% | 990,269 |
24-04-18 | 4.01 | -3.14% | 318,956 |
24-04-17 | 4.14 | -5.69% | 495,296 |
24-04-16 | 4.39 | -0.90% | 788,270 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+700.74% | 197M | |
-0.49% | 103B | |
+3.31% | 96.73B | |
+1.66% | 21.31B | |
-16.16% | 21.21B | |
-6.82% | 18.79B | |
-41.41% | 16.37B | |
-22.87% | 13.68B | |
+6.32% | 13.44B | |
+21.46% | 10.98B |
- Stock Market
- Equities
- ELEV Stock